Survey on the Current Activity of Medical Affairs Department in Japan

  • SHIMIZU Yutaka
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Mochida Pharmaceutical Co., Ltd., Medical Affairs
  • SONODA Ryotaro
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Mitsubishi Tanabe Pharma Corporation, Ikuyaku. Integrated Value Development Division Medical Affairs Department
  • FUJIWARA Kosaku
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Daiichi Sankyo Co., Ltd., Oncology Medical Science Department, Medical Affairs Division
  • NISHIMURA Takeshi
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Sumitomo Pharma Co., Ltd., Clinical Research, Drug Development Division
  • HOASHI Seiji
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Chugai Pharmaceutical Co., Ltd., Medical Affairs Div.
  • INOUE Naoki
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Nippon Shinyaku Co., LTD., Medical Affairs Division.
  • MURAKAMI Kohji
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Nippon Shinyaku Co., LTD., Medical Affairs Division.
  • TANAKA Nobuyuki
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Novo Nordisk Pharma Ltd., Medical Affairs Department
  • KANEKO Atsushi
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Biogen Japan Ltd., Medical
  • SHIINA Tetsuya
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Abbvie GK Medical
  • YAMASAKI Etsuko
    Japan Pharmaceutical Manufacturers Association (JPMA), Drug Evaluation Committee Merck Biopharma Co., Ltd., Medical department

Bibliographic Information

Other Title
  • 本邦におけるメディカルアフェアーズ活動の現況調査
  • Results of the Questionnaire Survey of External Experts
  • 社外医科学専門家に対するアンケート結果報告

Search this article

Journal

Details 詳細情報について

Report a problem

Back to top